These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 30049442)
1. PEGylated DC-Chol/DOPE cationic liposomes containing KSP siRNA as a systemic siRNA delivery Carrier for ovarian cancer therapy. Lee J; Ahn HJ Biochem Biophys Res Commun; 2018 Sep; 503(3):1716-1722. PubMed ID: 30049442 [TBL] [Abstract][Full Text] [Related]
2. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes. Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847 [TBL] [Abstract][Full Text] [Related]
3. Systemic delivery of Eg5 shRNA-expressing plasmids using PEGylated DC-Chol/DOPE cationic liposome: Long-term silencing and anticancer effects in vivo. Seraj S; Lee J; Ahn HJ Biochem Pharmacol; 2019 Aug; 166():192-202. PubMed ID: 31129050 [TBL] [Abstract][Full Text] [Related]
4. DC-Chol/DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery. Zhang Y; Li H; Sun J; Gao J; Liu W; Li B; Guo Y; Chen J Int J Pharm; 2010 May; 390(2):198-207. PubMed ID: 20116418 [TBL] [Abstract][Full Text] [Related]
5. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes. Hattori Y; Machida Y; Honda M; Takeuchi N; Yoshiike Y; Ohno H; Onishi H J Liposome Res; 2017 Dec; 27(4):264-273. PubMed ID: 27345333 [TBL] [Abstract][Full Text] [Related]
6. Mono-arginine Cholesterol-based Small Lipid Nanoparticles as a Systemic siRNA Delivery Platform for Effective Cancer Therapy. Lee J; Saw PE; Gujrati V; Lee Y; Kim H; Kang S; Choi M; Kim JI; Jon S Theranostics; 2016; 6(2):192-203. PubMed ID: 26877778 [TBL] [Abstract][Full Text] [Related]
7. Physicochemical Factors That Influence the Biocompatibility of Cationic Liposomes and Their Ability to Deliver DNA to the Nuclei of Ovarian Cancer SK-OV-3 Cells. Sun M; Yuan Y; Lu F; Di Pasqua AJ Materials (Basel); 2021 Jan; 14(2):. PubMed ID: 33466992 [TBL] [Abstract][Full Text] [Related]
8. Anti-angiogenic therapy via cationic liposome-mediated systemic siRNA delivery. Tagami T; Suzuki T; Matsunaga M; Nakamura K; Moriyoshi N; Ishida T; Kiwada H Int J Pharm; 2012 Jan; 422(1-2):280-9. PubMed ID: 22101286 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of VEGF expression in A431 and MDA-MB-231 tumour cells by cationic lipid-mediated siRNA delivery. Briane D; Slimani H; Tagounits A; Naejus R; Haddad O; Coudert R; Charnaux N; Cao A J Drug Target; 2012 May; 20(4):347-54. PubMed ID: 22475204 [TBL] [Abstract][Full Text] [Related]
10. Complexes containing cationic and anionic pH-sensitive liposomes: comparative study of factors influencing plasmid DNA gene delivery to tumors. Chen Y; Sun J; Lu Y; Tao C; Huang J; Zhang H; Yu Y; Zou H; Gao J; Zhong Y Int J Nanomedicine; 2013; 8():1573-93. PubMed ID: 23637529 [TBL] [Abstract][Full Text] [Related]
11. Effect of cationic lipid in cationic liposomes on siRNA delivery into the lung by intravenous injection of cationic lipoplex. Hattori Y; Nakamura M; Takeuchi N; Tamaki K; Shimizu S; Yoshiike Y; Taguchi M; Ohno H; Ozaki KI; Onishi H J Drug Target; 2019 Feb; 27(2):217-227. PubMed ID: 30024300 [TBL] [Abstract][Full Text] [Related]
12. Thermodynamic aspects and biological profile of CDAN/DOPE and DC-Chol/DOPE lipoplexes. Keller M; Jorgensen MR; Perouzel E; Miller AD Biochemistry; 2003 May; 42(20):6067-77. PubMed ID: 12755608 [TBL] [Abstract][Full Text] [Related]
14. Cationic liposome (DC-Chol/DOPE=1:2) and a modified ethanol injection method to prepare liposomes, increased gene expression. Maitani Y; Igarashi S; Sato M; Hattori Y Int J Pharm; 2007 Sep; 342(1-2):33-9. PubMed ID: 17566677 [TBL] [Abstract][Full Text] [Related]
15. Effects of sterol derivatives in cationic liposomes on biodistribution and gene-knockdown in the lungs of mice systemically injected with siRNA lipoplexes. Hattori Y; Saito H; Oku T; Ozaki KI Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165169 [TBL] [Abstract][Full Text] [Related]
16. Preparation of PEGylated cationic nanoliposome-siRNA complexes for cancer therapy. Haghiralsadat F; Amoabediny G; Naderinezhad S; Forouzanfar T; Helder MN; Zandieh-Doulabi B Artif Cells Nanomed Biotechnol; 2018; 46(sup1):684-692. PubMed ID: 29475393 [TBL] [Abstract][Full Text] [Related]
17. The use of cationic liposomes DC-CHOL/DOPE and DDAB/DOPE for direct transfer of Escherichia coli cytosine deaminase gene into growing melanoma tumors. Szala S; Missol E; Sochanik A; Strozyk M Gene Ther; 1996 Nov; 3(11):1026-31. PubMed ID: 9044744 [TBL] [Abstract][Full Text] [Related]
18. Enhanced gene delivery efficiency of cationic liposomes coated with PEGylated hyaluronic acid for anti P-glycoprotein siRNA: a potential candidate for overcoming multi-drug resistance. Ran R; Liu Y; Gao H; Kuang Q; Zhang Q; Tang J; Huang K; Chen X; Zhang Z; He Q Int J Pharm; 2014 Dec; 477(1-2):590-600. PubMed ID: 25448564 [TBL] [Abstract][Full Text] [Related]
19. Effect of the combination of cationic lipid and phospholipid on gene-knockdown using siRNA lipoplexes in breast tumor cells and mouse lungs. Hattori Y; Tang M; Aoki A; Ezaki M; Sakai H; Ozaki KI Mol Med Rep; 2023 Oct; 28(4):. PubMed ID: 37594053 [TBL] [Abstract][Full Text] [Related]
20. Quantitative silencing of EGFP reporter gene by self-assembled siRNA lipoplexes of LinOS and cholesterol. Metwally AA; Blagbrough IS; Mantell JM Mol Pharm; 2012 Nov; 9(11):3384-95. PubMed ID: 23057412 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]